Evox Therapeutics to Expand Its Work on Cell-targeted Delivery of Nucleic Acid-based Drugs

Accolade to Acquire PlushCare

Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition.

CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting

Experts will present its latest heart research, which was accepted at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, set to take place between April 24-28, 2021.

Dermatology Experts Present Latest Information at AAD VMX 2021

The AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair, and nails, presented by world-renowned experts in the field of dermatology.

October 20 2018

Evox Therapeutics Ltd, a leading exosome therapeutics company, today announces that it has secured an undisclosed amount of funding from the Bill & Melinda Gates Foundation. The funds will be used to support the Company’s development of cell-targeted exosome-based approaches to more effectively deliver a nucleic acid-based anti-infective drug.

Evox Therapeutics is engineering exosomes, the body’s natural vesicular delivery system, to enable a wide variety of drugs to reach previously inaccessible tissues and compartments, such as crossing the blood-brain barrier to deliver drugs to the central nervous system, intracellular delivery of biologics, and extra-hepatic delivery of RNA therapeutics.

Dr. Antonin de Fougerolles, Chief Executive Officer of Evox, commented: “We are pleased to be working with the Bill & Melinda Gates Foundation to maximize the effectiveness of their therapeutic drug through cell- and tissue-targeted exosome-mediated delivery. The foundation has a reputation for working with partners that can drive meaningful change – this funding is a testament to the quality of our platform and its potential application in areas of high medical need.”

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles